Pyramid Labs PT-141 10mg (Bremelanotide) is a melanocortin receptor agonist peptide researched for central nervous system effects on sexual desire and arousal pathways. FDA-approved as Vyleesi for specific indications, it is widely studied off-label in broader sexual function research.
Key Benefits:
- Increases sexual desire and reduces related distress (proven in premenopausal women with HSDD)
- Central (brain-based) mechanism distinct from PDE5 inhibitors
- Supports erectile function and sexual satisfaction in male research models
- Enhances libido and spontaneous arousal responses
- Improves overall sexual experience and partner satisfaction metrics in studies
Valuable for laboratories investigating hypoactive sexual desire disorder, melanocortin signaling, and sexual health pathways. Research use only.
Reviews
There are no reviews yet.